Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03985982Phase 3Completed
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)
Glabellar Frown Lines
PrincipalinvestigatorStart date: 2019-04-29

Research Network

Collaboration Network

7 collaborators·21 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Glabellar Frown Lines1

Affiliations

Perelman Center for Advanced Medicine-University of Pennsylvania

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rui Avelar, MD

Evolus, iInc.

Moderately Similar
1 trials

Shared therapeutic areas:

Glabellar Frown Lines
Similarity Score30%

Larry Fan, MD

77 Plastic Surgery

Moderately Similar
1 trials

Shared therapeutic areas:

Glabellar Frown Lines
Similarity Score30%

Beomjoon Kim, PI

Chung-Ang University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Glabellar Frown Lines
Similarity Score30%

John Joseph, MD

Clinical Testing of Beverly Hills

Moderately Similar
4 trials

Shared therapeutic areas:

Glabellar Frown Lines
Similarity Score30%

Rui Avelar

Evolus, Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Glabellar Frown Lines
Similarity Score30%

Michael Eppolito

Eirion Therapeutics

Moderately Similar
1 trials

Shared therapeutic areas:

Glabellar Frown Lines
Similarity Score30%

Shin Minkyung

Kyunghee University Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Glabellar Frown Lines
Similarity Score30%

Lee Jonghoon

Nown Eulji Medical Center, Eulji University

Moderately Similar
1 trials

Shared therapeutic areas:

Glabellar Frown Lines
Similarity Score30%

Peter Foley, Doctor

Austrailia

Moderately Similar
1 trials

Shared therapeutic areas:

Glabellar Frown Lines
Similarity Score30%

Andrea Schlӧbe, MD

Merz North America, Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Glabellar Frown Lines
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03985982Phase 3PrincipalInvestigator

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)

Glabellar Frown Lines
Completed

All 1 trials loaded